Find and connect with academic supervisors, professors, and scholars for your research journey.
Showing 1-11 of 11 supervisors
Profile data may be stale. It is sourced from public faculty pages.
Associate Professor
Rex Hung is an Associate Professor of Pathology at Harvard Medical School and serves as an Associate Pathologist at Massachusetts General Hospital . His academic career focuses on Bone and Soft Tissue Pathology , Cardiovascular Pathology , and Pulmonary Pathology , with significant contributions to cancer research.
Professor
G. Petur Nielsen, MD is a Professor of Pathology at Harvard Medical School and serves as Subspecialty Head, Bone and Soft Tissue Pathology at Massachusetts General Hospital . With a clinical focus on bone and soft tissue tumors, his expertise spans diagnostic pathology, molecular genetics of neoplasms, and ancillary testing applications. Research interests center on Pathology and biology of bone/soft tissue tumors Molecular genetics of bone and soft tissue neoplasms Chordoma and sarcoma research Epithelioid vascular tumor differentiation Mesenchymal tumors of the female genital tract His work includes landmark studies on tumor misdiagnosis rates, immunohistochemical profiling, and genomic analysis of chordomas. Scientific contributions appear in leading journals like Nature and American Journal of Surgical Pathology , with major emphasis on Molecular tumor classification Mutational signature analysis Translational oncology Diagnostic accuracy improvement Genomic instability mechanisms
Professor
Prof. Dr. med. Hans Roland Dürr is a Professor of Orthopedics and Trauma Surgery at Ludwig-Maximilians-University Munich, affiliated with the Faculty of Medicine. He specializes in orthopedic surgery and trauma surgery with particular focus on bone and soft tissue tumors. His clinical work is centered at the LMU Klinikum Campus Großhadern, where he serves at two locations: the Center for Bone and Soft Tissue Tumors (SarKUM) and the MUM - Clinic for Orthopedics, Trauma Surgery and Rehabilitative Medicine, both located at Marchioninistr. 15 in Munich. Prof. Dürr accepts both statutory insured and privately insured patients, maintaining an active clinical practice in orthopedics and trauma surgery. His expertise spans comprehensive orthopedic care, trauma management, and specialized treatment of bone and soft tissue pathologies. He is associated with the university hospital system that represents one of Germany's leading medical centers, contributing to both patient care and academic medicine through his clinical practice.
Professor
Peter M. Vogt serves as Professor and Head of the Department of Plastic, Hand and Reconstructive Surgery at Hannover Medical School, where he also directs the Burn Center. His clinical leadership spans reconstructive surgery using autologous tissue, peripheral nerve surgery, and aesthetic procedures. Dr. Vogt's research focuses on wound healing , tissue engineering , regenerative biology , and burn treatment . His work integrates clinical trials with translational approaches to improve outcomes in complex reconstructive cases. Recent publications emphasize infection management in hand surgery, burn reconstruction techniques, and biomaterial applications in skin regeneration. His scientific contributions have earned prestigious recognitions including the Langenbeck Award, National Biotechnology Award, and the Mowlem Lecture honor. Professional memberships span the American Association of Plastic Surgeons, European Burn Association, and multiple German surgical societies. As an educator, Dr. Vogt has held academic appointments since 1991 including Research Fellow at Harvard Medical School and Full Professor at Hannover since 2001. His clinical expertise covers trauma reconstruction, congenital malformations, and functional restoration after nerve paralysis.
Associate Professor
Ivan Chebib, MD is an Associate Professor of Pathology at Harvard Medical School and serves as Director of the Cytopathology Laboratory and Fine-Needle Aspiration Biopsy Service at Massachusetts General Hospital. He is board certified in Anatomic Pathology and Cytopathology by the American Board of Pathology and is certified as a fellow of the Royal College of Physicians of Canada. Dr. Chebib's educational background includes an MD from the University of Alberta, residency training at Foothills Medical Center, and fellowship training at Massachusetts General Hospital. His clinical focus encompasses cytopathology and bone and soft tissue surgical pathology. His research interests center on cytopathology and bone and soft tissue pathology, with particular expertise in immunohistochemistry. Dr. Chebib currently serves as the medical director of the Immunohistochemistry Laboratory at Massachusetts General Hospital. His publications span a range of topics including sarcoma diagnostics, bone pathology, and molecular characteristics of rare tumors. His recent work shows a strong focus on molecular pathology approaches to sarcoma diagnosis and classification, with publications in high-impact journals including Nature Medicine and Nature Communications. His research often addresses diagnostic challenges in bone and soft tissue tumors, with emphasis on improving diagnostic accuracy and understanding molecular mechanisms. As Director of the Cytopathology Laboratory, Dr. Chebib oversees all types of cytologic specimens including gynecologic and non-gynecologic cytology and fine needle aspiration biopsy services. The laboratory is staffed by eight cytopathologists, seven cytotechnologists, and other technical personnel, and is accredited for three cytopathology fellows. Dr. Chebib actively participates in teaching programs for residents and fellows at the hospital and medical school, contributing to the development of future pathology leaders. His work bridges clinical practice, diagnostic innovation, and research to advance the field of cytopathology and surgical pathology.
Researcher
Anna Streckenbach is a researcher affiliated with the Clinic and Polyclinic for Diagnostic and Interventional Radiology and Nuclear Medicine at the University Medical Center Hamburg-Eppendorf (UKE). Her work intersects biomedical engineering, orthopedic surgery, and radiology, with a focus on advanced imaging and 3D printing applications in surgical planning. Research interests include 3D printing for preoperative decision-making in complex fractures, periarticular soft tissue pathologies , and medical imaging innovations . Publications highlight her contributions to optimizing surgical workflows and understanding calcinosis. Key collaborations involve the Neuro-Immune Network Hamburg and interdisciplinary projects in cardiovascular and health services research. Contact: fis@uke.de .
Physician Scientist
Felix Benjamin Warwas is a Physician Scientist at the University of Bonn's Department of Oral and Maxillofacial Plastic Surgery within the Faculty of Medicine. He has been working as an Assistant Doctor ( Assistenzarzt ) at the Universitätsklinikum Bonn since January 2017 and is affiliated with Nils Heim's Lab. His educational background includes medical studies at: Yeshiva University (April 2016 - June 2016) Ruhr University Bochum (October 2015 - February 2021) Jagiellonian University (September 2014 - March 2015) Dr. Warwas specializes in Oral and Maxillofacial Pathology, Craniomaxillofacial Surgery, and Bone Pathology, with particular expertise in the microbiology of dental infections and applications of next-generation sequencing. His research bridges clinical practice and molecular diagnostics, focusing on improving pathogen identification in odontogenic abscesses and understanding microbial resistance patterns. He has also explored the intersection of artificial intelligence and medical education through studies evaluating GPT-4's performance in oral and maxillofacial surgery board exams. His publication record shows a consistent trajectory of research focused on improving diagnostic accuracy and treatment protocols in maxillofacial conditions, with recent work emphasizing molecular approaches to traditional clinical problems. The publications demonstrate expertise spanning from basic microbiology to clinical outcomes research and educational technology applications. His scientific recognition includes: Scholarship from the NRW Excellence Initiative (June 2012) Dr. Warwas collaborates extensively within the Department of Oral and Maxillofacial Plastic Surgery at the University of Bonn, working with colleagues including Valentin Wiedemeyer, Nils Heim, Anne Klausing, and others. His work appears to focus on both clinical research and practical applications that directly impact patient care in maxillofacial surgery and dentistry. His laboratory work within Nils Heim's research group appears to focus on molecular diagnostics for dental infections, bone pathology analysis, and innovative approaches to medical education assessment.
Professor
Univ.-Prof. Dr. med. Wolfgang Berdel serves as Professor in the Department of Hematology and Oncology at the Faculty of Medicine, University of Münster. His research is deeply integrated with the Multiscale Imaging Centre and the "Cells in Motion" interdisciplinary research cluster, focusing on translational oncology with emphasis on vascular-targeted therapies. Dr. Berdel's research program centers on tumor neo-angiogenesis , antivascular treatment strategies , and molecular mechanisms of leukemogenesis and oncogenesis . His laboratory pioneers approaches targeting tumor vasculature through engineered fusion proteins like tTF-NGR and antibody-cytokine conjugates, with particular focus on CD13 (aminopeptidase N) as a therapeutic target. His work bridges basic molecular oncology with clinical translation, evidenced by multiple phase I clinical trials. Analysis of his publication record reveals consistent focus on Tumor vascular infarction strategies using tissue factor variants Antibody-mediated drug delivery systems for leukemia and solid tumors Imaging biomarkers for vascular-targeted therapies Molecular mechanisms in acute myeloid leukemia pathogenesis His recent work increasingly incorporates advanced imaging techniques and computational approaches for treatment monitoring. Dr. Berdel maintains active collaborations across hematology, oncology, and imaging sciences at the University of Münster, particularly through the Multiscale Imaging Centre where his team develops novel therapeutic platforms targeting tumor vasculature. His laboratory works closely with clinical colleagues in translational research programs focused on improving outcomes for patients with hematological malignancies and solid tumors.
Associate Professor
Prof. Dr. Matthias Priemel is a Deputy Director and Associate Professor at the Hamburg University Medical Center (UKE), affiliated with the Faculty of Medicine. He specializes in Trauma Surgery and Orthopaedics, with a focus on musculoskeletal tumors and fracture healing. His roles include leadership in the Department of Trauma Surgery and expertise in surgical and diagnostic approaches for complex bone and soft tissue conditions. His research spans bone biology, imaging diagnostics, and oncological challenges in musculoskeletal systems. Affiliations: Clinic and Polyclinic for Trauma Surgery and Orthopaedics, UKE. Specialties: Surgical treatment of musculoskeletal tumors, trauma surgery, and bone healing mechanisms. Research Interests: Bone pathology, soft tissue tumors, imaging techniques, and biomaterial applications in surgery.
Associate Professor
Dieter Lindskog, MD, is an Associate Professor of Orthopaedics and Rehabilitation at Yale School of Medicine and Section Chief of Musculoskeletal Oncology. He serves as Disease Aligned Research Team Leader for the Sarcoma Program at Yale Cancer Center and directs the Smilow Cancer Hospital Sarcoma Tumor Board. Dr. Lindskog's clinical practice is directed nearly full-time at the treatment of patients with orthopaedic oncologic disease including sarcomas and metastatic disease to bone, a rare specialty in the medical field. Dr. Lindskog's research focuses on clinical study of patients with malignant and benign bone and soft tissue tumors. His investigations include evaluating outcomes for different reconstructive techniques after sarcoma resections and minimally invasive techniques for treating benign bone lesions. Recent work has centered on periacetabular osteolytic metastases and the AORIF (Ablation-Osteoplasty-Reinforcement-Internal Fixation) procedure, which has shown promise for pain management and functional preservation. His publication record demonstrates consistent scholarly output in high-impact journals including Cancers , Radiology , and Journal of Clinical Medicine , with research spanning surgical techniques, comparative outcomes, and natural history studies of musculoskeletal tumors. The publication trends show increasing focus on metastatic bone disease management and minimally invasive approaches to complex oncologic problems. Dr. Lindskog maintains active leadership roles in professional organizations: National Comprehensive Cancer Network – Bone Cancer Panel Member (2015-Present) AAOS Musculoskeletal Tumor & Metabolic Disease Program Committee (2017-Present) Musculoskeletal Tumor Society Fellowship Committee member (2016-Present) YNHH Orthopedic Residency Associate Program Director (2015-Present) As an educator, Dr. Lindskog contributes to medical student education through orthopaedic surgery clerkships and serves as Associate Program Director for the orthopaedic residency program. His clinical expertise in bone and soft tissue sarcoma represents a specialized area within orthopaedics that deals with 'life and death issues,' as he describes it, distinguishing it from much of general orthopaedic practice.
Assistant Professor
Harry Sanchez serves as Assistant Professor in both the Department of Pathology (Primary) and Department of Laboratory Medicine at Yale School of Medicine. He is Co-Director of the Legacy Tissue Donation Program and contributes to Yale Cancer Center's Cancer Signaling Networks Program, with additional appointments in Autopsy and Bone & Soft Tissue Pathology services. His research interests span Autopsy Pathology , Surgical Pathology , Microbiology , and Quality Management , with significant focus on medical education and historical aspects of pathology. The Legacy Tissue Donation Program under his co-direction provides critical resources for cancer researchers through rapid autopsy protocols that maintain tissue integrity for advanced genomic studies. Dr. Sanchez's 2016 publication reflects his collaborative work in surgical pathology, with research trends emphasizing tissue banking methodology and autopsy-based cancer progression analysis. His contributions support Yale's translational research infrastructure through rigorous quality management frameworks. As an educator, he trains pathology residents and medical students with dual emphasis on diagnostic excellence and historical context of pathological practices. His community pathology background at Hospital of Central Connecticut informs his practical approach to quality assurance systems in academic medical settings. Dr. Sanchez maintains active roles across Yale's clinical, research, and educational missions, with particular impact on tissue-based cancer research through the Legacy Tissue Donation Program's innovative rapid autopsy protocols.
